Lataa...
FDA Revisits Rules on Drug and Device Communication: Will the Agency Relax Existing Industry-Opposed Restrictions?
The Food and Drug Administration issued draft guidances in January that tackled health care economic information and product labeling. Do these publications indicate a potential shift in on- and off-label policies for drugs and devices?
Tallennettuna:
| Julkaisussa: | P T |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MediMedia USA, Inc.
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5312633/ https://ncbi.nlm.nih.gov/pubmed/28250700 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|